Mercury Labs Reports Decline in Q1 FY25 Financial Results, Remains Committed to Improvement

Jul 24 2024 03:30 PM IST
share
Share Via
Mercury Laboratories, a microcap pharmaceutical company, reported a negative performance in the quarter ending June 2024, with a decrease in PAT and Net Sales. Despite this, the company remains committed to improving its performance and investors are advised to hold their stocks and monitor its progress in the near term.

Mercury Laboratories, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending June 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Mercury Labs has seen a negative performance in the quarter, with a score of -6 compared to 8 in the previous quarter. This decline can be attributed to various factors, including a significant decrease in Profit After Tax (PAT) and Net Sales.


The company’s PAT for the quarter was at Rs 0.34 crore, which is a decrease of 76% from the average PAT of the previous four quarters. Similarly, the Net Sales for the quarter were at Rs 16.68 crore, a decrease of 11.7% from the average of the previous four quarters. This trend is expected to continue in the near term.


Mercury Labs also saw a decline in its Operating Profit (PBDIT) and Profit Before Tax less Other Income (PBT) for the quarter, with both being at their lowest in the last five quarters. The company’s Earnings per Share (EPS) also saw a decline, indicating a decrease in profitability and lower earnings for shareholders.


Despite these negative financial results, Mercury Laboratories remains a strong player in the pharmaceutical industry. The company is committed to improving its performance and is constantly working towards achieving its goals. Investors are advised to hold their stocks and monitor the company’s progress in the coming quarters.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News